Congenital melanocytic nevi (CMN) have an estimated prevalence of between 0.5% and 31.7%. [1] [2] [3] [4] [5] CMN larger than 20 cm are uncommon with an estimated incidence of between 1 in 20,000 to 1 in 500,000 births. 2, 6 The current classification of CMN (Fig 1) is based mainly on the maximum diameter that the nevus is predicted to attain during adulthood. 7 A CMN is classified as large-1 if it measures between 20 to 30 cm, large-2 if it measures between 30 and 40 cm, giant-1 if it measures between 40 and 60 cm, and giant-2 if greater than 60 cm in maximal diameter. 7 This classification scheme also includes additional morphologic characteristics of the CMN: anatomic localization, degree of color heterogeneity, surface rugosity, hypertrichosis, dermal/subcutaneous nodularity, and number of smaller satellite nevi.
To highlight the distribution of giant CMN (GCMN), Bircher, 8 in 1897, used terms such as ''bathing trunk,'' ''vest-like,'' and ''vest with collar.'' In 1965, Reed et al 9 described 55 patients using terms such as ''bathing trunk,'' ''shoulder stole'' or ''cape-like,'' ''coat sleeve,'' and ''stocking-like.'' In 2005, Torrelo et al 10 separated 1188 nevi based on the following morphologic categories: round, patchy indented or triangular shape, agminated, diffuse patchy, Blaschkolinear, block/flag-like, and garment-like distribution.
Based on the garment-related terms used to describe the distribution patterns of large or GCMN, we hypothesized that GCMN have repetitive recognizable patterns of distribution. The aim of this study was to evaluate the distribution patterns of GCMN and to determine whether recognizable patterns emerge.
METHODS

Phase I
A query of the medical records at the Hospital Clinic of Barcelona was performed to identify patients diagnosed with GCMN between 1975 and 2013. The charts were reviewed to identify patients who had full-body clinical photographs of CMN with a projected adult size larger than 40 cm and in whom the full extent (location, distribution, and size) of the GCMN was visible on the photographs. The included cases were analyzed by 2 observers to determine the patterns of distribution and to create an anatomic distribution classification with initial definitions and schematics termed as the ''6B'' (Fig 2) . Two other observers independently reclassified the same cases using the proposed classification scheme. Cases that presented disagreement in the classification were jointly re-evaluated for consensus. This exercise lead to fine-tuning of the classification and the final schematic was created ( Fig  2) . Two different observers independently classified the cases according to the proposed final classification scheme and interobserver agreement was assessed.
Phase II To test the reproducibility and applicability of the 6B classification scheme, an atlas of published images of patients with GCMN was assembled. All articles identified via literature search using PubMed containing the terms ''giant congenital nevi'' and published between January 1, 1998, and April 30, 2014, were evaluated for the presence of images of GCMN. Images were selected if they met the following criteria: (1) images showing the GCMN with a projected adult size larger than 40 cm in which the entire GCMN was visible with back, front, and/or side body sectors shown; and (2) images showing the main portion of the GCMN with a written description that adequately helped the reader appreciate the full extent of its distribution. Images excluded from the study atlas included those showing only a portion of the GCMN where the full extension of the GCMN could not be deciphered, case reports that were deemed not to represent CMN or GCMN, duplicate images of the same patient in multiple publications, and GCMN where portions of the nevus had been excised.
The workflow for phase II of this study is shown in Fig 3. All cases included in the study atlas were classified according to the 6B classification scheme by 8 physicians. Two weeks later, 4 of the 8 physicians classified all cases for a second time. They did not have access to the answers previously provided. The new answers were used to assess the intraobserver agreement.
Statistical analysis
All statistical analyses were performed using software (SPSS Statistics for Windows, Version 22.0, IBM Corp, Armonk, NY). Descriptive data were
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d Garment-related terms have been used to describe the anatomic localization of giant congenital melanocytic nevi. d A classification scheme, with good interobserver agreement, is proposed to standardize the distribution patterns of giant melanocytic nevi. d A simple, reliable, and repeatable classification can help to improve communication and patient risk stratification. reported as mean 6 SD and/or as percentages. Interobserver and intraobserver agreement between the 2 evaluators in phase I was assessed by unweighted kappa. In phase II, the interobserver agreement between evaluators was assessed by Fleiss kappa. The results were interpreted based on the proposed 5 levels of Landis and Koch 11 with values of 0 to .20 representing slight agreement, .21 to .40 fair agreement, .41 to .60 moderate agreement, .61 to .80 substantial agreement, and .81 to 1 almost perfect agreement.
Ethical issues
The study complied with the Declaration of Helsinki Principles and was approved by the Clinical Research Ethics Committee of the Hospital Clinic of Barcelona.
RESULTS
Phase I
In all, 24 patients with GCMN were identified after review of the medical records. Two patients were excluded because images revealed that significant portions of the GCMN had been excised. The remaining 22 patients ranged in age between 4 days and 51 years at the time the images were acquired. The majority of patients (68.2%) were younger than 10 years. Thirteen patients were female (59.1%). Four patients had neurocutaneous melanosis (NCM), 2 of whom had a primary central nervous system melanoma and died from their disease.
The interobserver agreement between 2 observers using the initial 6B classification scheme was 0.758. After refinements, resulting in the final version of the classification, the overall agreement between 2 observers improved to 1. The kappa values for each of the 6B patterns in each phase of the study are presented in Table I . Fig 2 defines the 6B patterns of distribution via schematics and images depicting exemplar cases. The most frequent distribution pattern observed was bathing trunk (45.5%), followed by bolero (27.4%), back (13.6%), breast/ belly (4.5%), body (4.5%), and body extremity (4.5%).
Phase II
From the literature search we identified 275 potential articles containing images of GCMN. We ultimately found 113 images of cases of GCMN that met our inclusion criteria. The overall interobserver agreement among the 8 observers resulted in a kappa of 0.891 (0.722-0.962). The 4 observers who evaluated the cases at 2 separate time points had intraobserver agreement kappa scores of 0.941, 0.942, 0.927, and 0.913 (mean 0.931). Most frequently observed was the bathing trunk pattern (39.8% of cases) followed by bolero (23%), back (17.7%), breast/belly (8%), body extremity (9.7%), and body (1.8%).
DISCUSSION
Our study highlights that GCMN follow reproducible distribution patterns represented by the 6Bs (Fig 2) . This scheme can be used to classify the distribution pattern of most/all GCMN reported in the literature with high levels of intraobserver and interobserver agreement.
It has been shown that phenotypic characteristics of individuals with GCMN can help predict risk for developing NCM, melanoma, or other complications. The risk for developing melanoma correlates with the size of the CMN, 12 and the number of satellite nevi has been shown to correlate with risk for developing NCM. 13 The phenotype may also provide insight regarding the timing of events during embryogenesis. For example, ''kissing nevi'' on the eyelids (a CMN with one portion located on the upper eyelid and the other on the lower eyelid) indicate that the aberrant melanocyte migration took place between the 9th week of embryogenesis, when the upper and lower lids fuse, and the 20th week, when the lids separate. 14, 15 The location of the GCMN may also be a factor or a surrogate marker of risk. It has been suggested that the bathing trunk pattern may be associated with an increased risk for melanoma and NCM. 9 The bathing trunk distribution encountered in 45.5% of our patients (n = 10) and in 39.8% (n = 45) of cases reported in the literature, compares with previously reported figures of 44% (n = 15) 8 and 47.3% (n = 26). 9 This pattern was observed in 33 of 39 published patients with melanoma and in 12 of 20 patients with NCM. 9 It is noteworthy that our 2 patients who died from melanoma presented with a bathing trunk GCMN. Although the descriptor ''bathing trunk'' is commonly used, no clear or agreed upon definitions exist for this or other garment-related terms.
Future studies incorporating molecular information together with genetic, environmental, and other factors related to embryogenesis may someday help explain why GCMN are distributed in these patterns. It is likely that a combination of factors including the type of mutation, the location of the progenitor J AM ACAD DERMATOL mutated cell, the timing of the mutation being expressed during embryogenesis, and the presence of polymorphisms all play a role in sculpting the morphology and distribution patterns encountered in GCMN.
Our study has limitations. GCMN are rare and some of the patterns described in the 6B scheme are seen infrequently. This may explain why some patterns had lower interobserver agreements. Multicenter studies with a larger number of cases are required to validate our findings. The 6B classification scheme for GCMN excluded nevi located on the head because very few nevi in this location were found to be larger than 40 cm. However, a classification scheme incorporating nevi located on the head should be considered.
In conclusion, our study found that most GCMN can be categorized into 1 of 6 distinct anatomic distribution patterns with good interobserver and intraobserver agreement. Based on our study we propose the standardization of terminology used to describe GCMN garment distribution patterns. We favor addition of the 6B classification scheme to the recently reported recommendations for the categorization of cutaneous features of CMN to facilitate collaborative research and allow for more reliable comparisons of study findings.
